Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.

A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over increased transmissibility. The new variant comes from the clade 1a strain ...

The only antiviral recognised as an mpox treatment was unable to shorten the time to resolution of lesions in a trial in the Democratic Republic of the Congo (DRC), the epicentre of an outbreak ...

Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within families and among children, whereas the 2022 Clade II mpox - still ...

The study addresses a critical question in public health: could mpox evolve to become efficiently airborne like its viral relative, smallpox? While close physical contact remains the dominant mode ...

New data on Mpox vaccine effectiveness Date: March 19, 2025 Source: Charité - Universitätsmedizin Berlin Summary: A study has found that a single dose of the Imvanex vaccine provides protection ...

MITI MURHESA, Congo (AP) — Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and ...

A study at Charité – Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose ...

“The high transmittance rate of the clade 1a Mpox variant is likely due to mutations the virus has picked up – exactly how these impact transmission isn’t currently clear and more research ...